Skip to main content
Premium Trial:

Request an Annual Quote

Sloning BioTechnology

Sloning BioTechnology announced late last week it now is offering a custom mutant library construction service. SlonoMax libraries are made up exclusively of desired mutant proteins in defined proportions.
In a statement, Sloning said that the production of such protein variant libraries has typically resulted in the presence of undesirable mutations and unequal representation of desired variants.
SlonoMax uses Slonomics technology, which enables the parallel construction of variants based on the use of triplet building blocks, the company said. This allows for the targeted assembly of proteins “with the desired codons at each sequence position.”

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.